Ezh2 (Enhancer of zeste homolog 2) protein is the enzymatic component of the Polycomb repressive complex 2 (PRC2), which represses gene expression by methylating lysine 27 of histone H3 (H3K27) and regulates cell proliferation and differentiation during embryonic development. Recently, hot-spot mutations of Ezh2 were identified in diffused large B-cell lymphomas and follicular lymphomas. To investigate if tumor growth is dependent on the enzymatic activity of Ezh2, we developed a potent and selective small molecule inhibitor, EI1, which inhibits the enzymatic activity of Ezh2 through direct binding to the enzyme and competing with the methyl group donor S-Adenosyl methionine. EI1-treated cells exhibit genome-wide loss of H3K27 methylation and activation of PRC2 target genes. Furthermore, inhibition of Ezh2 by EI1 in diffused large B-cell lymphomas cells carrying the Y641 mutations results in decreased proliferation, cell cycle arrest, and apoptosis. These results provide strong validation of Ezh2 as a potential therapeutic target for the treatment of cancer.

The evolutionary forces that establish and hone target gene networks of transcription factors are largely unknown. Transposition of retroelements may play a role, but its global importance, beyond a few well described examples for isolated genes, is not clear. We report that LTR class I endogenous retrovirus (ERV) retroelements impact considerably the transcriptional network of human tumor suppressor protein p53. A total of 1,509 of Ϸ319,000 human ERV LTR regions have a near-perfect p53 DNA binding site. The LTR10 and MER61 families are particularly enriched for copies with a p53 site. These ERV families are primate-specific and transposed actively near the time when the New World and Old World monkey lineages split. Other mammalian species lack these p53 response elements. Analysis of published genomewide ChIP data for p53 indicates that more than one-third of identified p53 binding sites are accounted for by ERV copies with a p53 site. ChIP and expression studies for individual genes indicate that human ERV p53 sites are likely part of the p53 transcriptional program and direct regulation of p53 target genes. These results demonstrate how retroelements can significantly shape the regulatory network of a transcription factor in a species-specific manner.

Polycomb repressive complex 2 (PRC2) consists of three core subunits, EZH2, EED and SUZ12, and plays pivotal roles in transcriptional regulation. The catalytic subunit EZH2 methylates histone H3 lysine 27 (H3K27), and its activity is further enhanced by the binding of EED to trimethylated H3K27 (H3K27me3). Small-molecule inhibitors that compete with the cofactor S-adenosylmethionine (SAM) have been reported. Here we report the discovery of EED226, a potent and selective PRC2 inhibitor that directly binds to the H3K27me3 binding pocket of EED. EED226 induces a conformational change upon binding EED, leading to loss of PRC2 activity. EED226 shows similar activity to SAM-competitive inhibitors in blocking H3K27 methylation of PRC2 target genes and inducing regression of human lymphoma xenograft tumors. Interestingly, EED226 also effectively inhibits PRC2 containing a mutant EZH2 protein resistant to SAM-competitive inhibitors. Together, we show that EED226 inhibits PRC2 activity via an allosteric mechanism and offers an opportunity for treatment of PRC2-dependent cancers.

Mesoporous carbon with graphitic pore walls is highly desired in many electrochemical applications such as fuel cells and lithium ion batteries. In this study, ordered graphitic mesoporous carbon was prepared by chemical vapor deposition (CVD) of benzene in the pores of mesoporous SBA-15 pure-silica template without loading any catalytic species. Nitrogen adsorption, small-angle X-ray scattering, X-ray diffraction, Raman spectrometry, field-emission scanning electron microscopy, transmission electron microscopy, and thermogravimetric analysis techniques were used to characterize the samples. It was observed that the CVD method affords highly ordered mesoporous carbon with graphitic pore walls and low carbon shrinkage because of the high degree of infiltration of pyrolytic carbon. The catalytic performance of the mesoporous carbon as a support for Pt catalyst in room-temperature methanol oxidation was examined. Results show that the specific activity of the Pt catalyst supported on the mesoporous carbon is higher than that of a commercial Pt catalyst form E-TEK.

Core-shell Au-Pt nanoparticles with intimate contact of Pt and Au were prepared by a displacement reaction without formation of monometallic Au nanoparticles. The Au-Pt nanoparticles were dispersed on carbon (Au@Pt/C) and were used to catalyze methanol electrooxidation in acidic solutions at room temperature. The core-shell nanostructure was confirmed by transmission electron microscopy and X-ray photoelectron spectroscopy, and specific catalytic activities were evaluated by CO anodic stripping voltammetry in 0.5 M H(2)SO(4) and by cyclic voltammetry in 1 M CH(3)OH + 0.5 M H(2)SO(4). The Au@Pt/C catalyst demonstrated enhanced specific activity in methanol electrooxidation and showed multiple CO stripping peaks which were all negatively shifted with respect to a similarly prepared Ag@Pt/C catalyst. The activity enhancement is attributed to the presence of Au underneath a very thin Pt shell where electron exchange between Au and Pt had promoted the formation of active oxygen species on Pt, which facilitated the removal of inhibiting CO-like reaction intermediates.